Skip to search formSkip to main contentSkip to account menu

Dixarit

Known as: Boehringer Ingelheim Brand of Clonidine Hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND Tourette syndrome (TS) is a neurodevelopmental condition characterised by chronic motor and vocal tics affecting up to… 
2005
2005
ZusammenfassungBei 11 Frauen mit menopausaler Symptomatik wurde eine Behandlung mit 150 μg Clonidin (Dixarit) täglich durchgef… 
1982
1982
  • C. Lauritzen
  • Deutsche medizinische Wochenschrift
  • 1982
  • Corpus ID: 21344712
Clonidine (Dixarit), 0.025 mg three times daily, was given to 15 patients with menopausal, predominantly vasomotor symptoms. Both… 
Highly Cited
1980
Highly Cited
1980
Clonidine, 0.05 mg twice daily, was evaluated in a multicentre, randomized, placebo-controlled, double-blind crossover study in… 
1980
1980
Twenty-three cases of the climacteric syndrome were analysed in a double-blind study comparing the effect of conjugated equine… 
1979
1979
Results of an open evaluation of the therapy with low‐dosage Clonidine (Dixarit) in a series of 20 patients with symptoms of… 
1978
1978
without TCA, compared with 6/10 patients during treatment. Minor arrhythmias, such as occasional atrial premature beats (APBs… 
1978
1978
formulation as blue-coloured, sweet-tasting tablets, and in the fact that it is prescribed for migraine, a relatively non-serious…